Amy Jaramillo is the Scientific Director at BodyScience, a pioneering functional medicine center specializing in the treatment of neurodegenerative diseases, including Alzheimer’s, Parkinson’s, Multiple Sclerosis, and Amyotrophic Lateral Sclerosis (ALS). Since 2019, she has been credited with four recognized ALS recoveries and numerous cases where disease progression has been successfully halted. An expert in cellular science and pathway-focused therapies, Amy is a strategist whose approach includes the use of peptides for cellular signaling, stem cell therapies, fecal microbiota transplants, and other novel therapies to address underlying dysfunctions. Recognizing the significant role that chronic low-level infections play in aging, immune dysfunction, and chronic disease, she incorporates advanced pathogen control strategies, such as Supportive Oligonucleotide Therapy (SOT), to effectively manage and reverse disease processes. Amy's innovative work continues to provide hope and improved outcomes for patients facing complex chronic illnesses.